Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
Public ClinicalTrials.gov record NCT00064623. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Painful HIV-Associated Distal Symmetrical Polyneuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is effective in treating painful HIV-associated neuropathy.
Study identification
- NCT ID
- NCT00064623
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2003
- Primary completion
- Not listed
- Completion
- Oct 31, 2005
- Last update posted
- Mar 5, 2008
2003 – 2005
United States locations
- U.S. sites
- 35
- U.S. states
- 18
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NeurogesX Investigational Site | Phoenix | Arizona | 85006 | — |
| NeurogesX Investigational Site | Phoenix | Arizona | 85023 | — |
| NeurogesX Investigational Site | Berkeley | California | 94609 | — |
| NeurogesX Investigational Site | San Diego | California | 92103 | — |
| NeurogesX Investigational Site | San Francisco | California | 94117 | — |
| NeurogesX Investigational Site | Stanford | California | 94305 | — |
| NeurogesX Investigational Site | West Hollywood | California | 90069 | — |
| NeurogesX Investigational Site | Fort Lauderdale | Florida | 33306 | — |
| NeurogesX Investigational Site | Miami | Florida | 33133 | — |
| NeurogesX Investigational Site | Miami | Florida | 33136 | — |
| NeurogesX Investigational Site | North Palm Beach | Florida | 33408 | — |
| NeurogesX Investigational Site | Orlando | Florida | 32804 | — |
| NeurogesX Investigational Site | Sunrise | Florida | 33351 | — |
| NeurogesX Investigational Site | Vero Beach | Florida | 32960 | — |
| NeurogesX Investigational Site | Honolulu | Hawaii | 96816 | — |
| NeurogesX Investigational Site | Chicago | Illinois | 60612 | — |
| NeurogesX Investigational Site | Lexington | Kentucky | 40536 | — |
| NeurogesX Investigational Site | Baltimore | Maryland | 21205 | — |
| NeurogesX Investigational Site | Boston | Massachusetts | 02215 | — |
| NeurogesX Investigational Site | Springfield | Massachusetts | 01107 | — |
| NeurogesX Investigational Site | Detroit | Michigan | 48201 | — |
| NeurogesX Investigational Site | Minneapolis | Minnesota | 55416 | — |
| NeurogesX Investigational Site | St Louis | Missouri | 63108 | — |
| NeurogesX Investigational Site | Camden | New Jersey | 08103-1489 | — |
| NeurogesX Investigational Site | Albany | New York | 12208 | — |
| NeurogesX Investigational Site | New York | New York | 10021 | — |
| NeurogesX Investigational Site | New York | New York | 10029 | — |
| NeurogesX Investigational Site | Chapel Hill | North Carolina | 27599 | — |
| NeurogesX Investigational Site | Cleveland | Ohio | 44106 | — |
| NeurogesX Investigational Site | Portland | Oregon | 97209 | — |
| NeurogesX Investigational Site | Austin | Texas | 78705 | — |
| NeurogesX Investigational Site | Dallas | Texas | 75208 | — |
| NeurogesX Investigational Site | Houston | Texas | 77030 | — |
| NeurogesX Investigational Site | San Antonio | Texas | 78229 | — |
| NeurogesX Investigational Site | Madison | Wisconsin | 53792-5132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00064623, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2008 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00064623 live on ClinicalTrials.gov.